Gene expression correlation of immune checkpoint molecules Siglec-15 and PD-L1 varies widely by cancer indication

被引：0
|
作者：
Watkins, Krystal
Diao, Liyang
Crochiere, Marsha
Pinkas, Jan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1373
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors
    Hashimoto, Kazuhiko
    Nishimura, Shunji
    Shinyashiki, Yu
    Ito, Tomohiko
    Kakinoki, Ryosuke
    Akagi, Masao
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2023, 67 (02):
  • [32] Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas
    Hashimoto, Kazuhiko
    Nishimura, Shunji
    Ito, Tomohiko
    Akagi, Masao
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2021, 65 (03):
  • [33] INTRATUMORAL EXPRESSION OF PD-1/PD-L1 IMMUNE CHECKPOINT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Baquerizo, Angeles
    Vavinskaya, Vera
    Rojas, Angela
    Mhoyan, Anna
    Romero-Gomez, Manuel
    Sher, Linda
    Madani, Bahar
    Fisher, Jonathan
    Schaffer, Randolph
    Frenette, Catherine T.
    Marsh, Christopher
    HEPATOLOGY, 2019, 70 : 206A - 206A
  • [34] Stomach cancer. clinical significance of the expression of key components of pd-1/pd-l1 immune checkpoint
    Kovaleva, Olga V.
    Podlesnaya, Polina A.
    Gratchev, Alexei N.
    Chang, Victor L.
    Ognerubov, Nikolai A.
    Kushlinskii, Nikolai E.
    Journal of Nonlinear and Variational Analysis, 2021, 5 (03): : 122 - 127
  • [35] Siglec-15/sialic acid axis as a central glyco- immune checkpoint in breast cancer bone metastasis
    Wang, Yixian
    Xu, Zhan
    Yu, Liqun
    Wang, Chenhang
    Ding, Haoxue
    Gao, Yang
    Sun, Han
    Xia, Meng
    Chen, Yuda
    Wu, Kuan- Lin
    Wu, Yi-Hsuan
    Xiao, Han
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (05)
  • [36] EXPRESSION OF IMMUNE CHECKPOINT MOLECULES (PD-1, PD-L1, AND PD-L2) ON BONE MARROW T CELLS IN ACUTE MYELOID LEUKEMIA
    You, E.
    Park, C. -J.
    Cho, Y. -U.
    Yoon, C. H.
    Jang, S.
    Im, H. J.
    Seo, J. J.
    Lee, J. -H.
    Lee, K. -H.
    HAEMATOLOGICA, 2017, 102 : 373 - 374
  • [37] PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer
    Zhao, Lei
    Cao, Yaming
    DISEASE MARKERS, 2020, 2020
  • [38] Expression of the immune checkpoint molecules PD-L1 and PD-1 in EBV-associated lymphoproliferative disorders: A meta-analysis
    Yu, Junyao
    Jin, Shenhe
    Yin, Xiufeng
    Du, Huaping
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (01)
  • [39] Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint
    Gu, Tingxuan
    Tian, Xueli
    Wang, Yuanyuan
    Yang, Wenqian
    Li, Wenwen
    Song, Mengqiu
    Zhao, Ran
    Wang, Mengqiao
    Gao, Quanli
    Li, Tiepeng
    Zhang, Chengjuan
    Kundu, Joydeb Kumar
    Liu, Kangdong
    Dong, Zigang
    Lee, Mee-Hyun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Prospective role of PD-1/PD-L1 immune checkpoint inhibitors in GI cancer
    AmeliMojarad, Mandana
    AmeliMojarad, Melika
    Cui, Xiaonan
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 244
12345